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checks and delivered a public awareness 
campaign to raise the profile of the  
condition and the associated stroke risk.    
Building on these actions, NICHS 
commissioned this Independent Inquiry in 
March 2019 to gain a better understanding 
of the key issues relating to AF detection 
and management in Northern Ireland and 
to help identify solutions to address those 
issues. The Inquiry research ran from  
March 2019 to January 2020.
We would like to thank all of those who 
took the time to contribute to the Inquiry. 
We would particularly like to extend our 
sincere thanks and appreciation to those 
people who shared their personal stories 
and experiences of living with AF and to 
members of the advisory panel who provided 
invaluable advice, expertise, and their time. 
NICHS looks forward to working in 
partnership to ensure the recommendations 
from this report are taken forward to 
improve the outcomes and experience of 
people living with AF. By doing this we can 




Northern Ireland  
Chest Heart & Stroke
Atrial Fibrillation (AF) is one of the most 
common types of irregular heart rhythm 
and someone with this condition could  
be up to five times more likely to suffer  
a stroke. This medical condition can have 
a devastating impact on the individual 
and their family. In addition it has 
consequences for the health and social 
care sector, the economy and our society. 
Whilst recognising that there are many 
examples of good practice, we believe 
that improvements can be made in the 
management of those who suffer from AF.
It is deeply concerning that there are an 
estimated 10,000 people in Northern 
Ireland living with AF yet undiagnosed.   
They will not be aware their risk of a stroke 
could be greatly diminished by treatment 
with basic medication.
By engaging directly with people in local 
communities Northern Ireland Chest 
Heart and Stroke (NICHS) staff witness 
the devastating impact of AF every day. 
Through our Stroke Groups we have met 
with numerous people who received their 
diagnosis of AF post stroke, a stroke that 
may very well have been prevented if their 
AF had been identified earlier. NICHS is very 
aware of the need to do more to prevent, 
delay, and manage such a serious condition.  
NICHS prides itself on championing re-design 
and innovation in health services. We have 
been leading by example in Northern Ireland 
in the area of AF.  In recent years NICHS has 
introduced AF testing as part of our health 
FOREWORD
Did you know?
Over 37,000 people in NI are living 
with AF although it is estimated 
that many more are living with the 
condition undetected. Could you  
be one of them?
• People with AF are likely to have  
a much more severe stroke with:
• Almost double the death rate 
from stroke
• Increased disability from stroke
• Longer hospital stay




What are the Symptoms of AF?
Sometimes people with AF have 
no symptoms and their condition 
is only detectable during a medical 
examination or by having a health 
check with us.
Some people may experience 
one or more of the following 
symptoms:
• Feeling very tired
• Feeling faint at times
• Being breathless 
•  Palpitations or fluttering or 
‘thumping’ in the chest
AF (irregular heartbeat) increases  
your risk of stroke by five times.
It’s time to talk about AF.
Have you heard of AF?
In a recent survey we conducted of 1000 people, 700 did not 
know what AF is. Only 3% knew that having AF increased your  
risk of stroke five fold.
Artwork from NICHS AF Factsheet
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ADVISORY PANEL SUMMARY OF KEY 
RECOMMENDATIONS
Panel members:
1. Dr John Winter - Chairperson & GP Lead of the Ards Integrated  
Care Partnership  
2. Dr Brian Gallen – Consultant Stroke Physician and Geriatrician,  
South West  Acute Hospital and member of NICHS Governance Board
3. Michael Jackson – Lead Pharmacist for Cardiothoracic Services, 
Belfast Health and Social Care Trust 
4. Neil Johnston – Public Affairs & Policy Manager, NICHS 
5. Dr Niamh Kennedy – Lecturer in Psychology, Ulster University 
6. Clare Murray - Lead GP Pharmacist, East Belfast Federation  
of Family Practices 
The role of the panel was to ensure that the appointed researcher,  
Dr Niamh Kennedy, was able to regularly consult and seek advice from 
several healthcare professionals from across Northern Ireland with  
differing professional backgrounds.
Neil Johnston spoke with a wide number of people who attend our NICHS 
Stroke Groups to understand their experience of stroke in general and AF 
 in particular.
Dr. Kennedy conducted one to one interviews with people living with  
AF about their experiences of living with this condition and over  
40 people with AF responded to our patient survey.
1. Develop an AF strategy for Northern 
Ireland which will:
• drive forward service improvement 
 in awareness, detection, support,  
and management   
• have a clear implementation with 
targets and timelines – including the 
appointment of an ‘AF Champion’.  
2. Establish a target to achieve at least 85% 
detected prevalence across Northern 
Ireland by March 2023 and have a 
proposed ambition of identifying 90%  
of expected prevalence by 2025. 
3. Create a holistic clinical pathway for  
AF in Northern Ireland involving patients 
and clinicians.
4. Invest in the use of proven technologies 
within clinical practice to detect AF, 
monitor implementation Plan, and  
allow audit.
5. Commission plans to increase AF 
detection rates by using targeted case 
finding based on AF risk factors. 
6. Take action to address the 
echocardiograms waiting list issue, 
including outlining plans to tackle  
any workforce issues.  
7. Provide information and education to 
people living with AF to better support 
understanding, improve adherence 
to anticoagulation medication, and to 
manage their condition. 
8. Prioritise improving treatment  
and review of existing AF patients  
to prevent future strokes.  
We recommend the following targets:
• Achieve less than 20% of patients  
with known AF admitted with  
stroke not correctly anticoagulated  
by March 2023
• Reduce individuals with a new 
diagnosis of AF after admission  
to a stroke unit from 23% to 20%  
by March 2023.
9. Commission the Public Health  
Agency to identify the most  
effective methods to raise public 
awareness of AF. We recommend  
the following targets:  
• increase public recognition of AF  
from 37% of the population to 50%  
of the population by 2025
• increase public awareness that AF  
can increase the risk of stroke by up  
to five times from the current base  
of 11% to 20% by 2025.
Working in partnership with key stakeholders,  
the Department of Health should:
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INTRODUCTION
Key points: 
In Northern Ireland 
• AF is the most common sustained heart rhythm. 
• Nearly 40,000 (80%) of people have been diagnosed  
with AF. 
• It is estimated there are at least 10,000 people undiagnosed.
• AF can increase the risk of stroke by 5 times (more than  
any other cardiovascular risk factor).
• Between 30-40% of people may not be aware they have AF  
until they have a stroke. 
• Up to 25% of ischaemic strokes due to occur because of AF.
• Approximately 2,800 people have a stroke every year.
• Stroke is the third biggest cause of death. With over 1,000  
deaths per year.
• 10% of high-risk AF patients are not anticoagulated.
• The cost of caring for stroke in NI is projected to rise from  
£484 million in 2015 to £1.51 billion in 2035.
• Estimated potential £4 billion (UK) saving to societal  
costs of stroke by 2035 through investment in improved  
stroke prevention.
What is Atrial  
fibrillation (AF)?
Atrial fibrillation (AF) is a heart condition 
that causes an irregular and often 
abnormally fast heart rate. In a normal  
heart, blood is pumped through the heart  
by the tightening and relaxing of the 
muscular walls.  This pumping action is 
controlled by part of the heart called the 
sinus node which sends regular electrical 
impulses to control the rhythm.
 AF happens when irregular electronic 
impulses are sent to the hearts upper 
chambers (atria), which overrides the hearts 
natural pacemaker meaning it can no longer 
control the regular rhythm of the heart.
There are several definitions of AF and  
the condition can progress through  
these stages.
• Paroxysmal atrial fibrillation is AF that 
comes and goes. It usually lasts for less 
than 48 hours but can last for up to seven 
days. The heart reverts to normal rhythm 
by itself and AF is not there all the time.
• Persistent atrial fibrillation is when 
each episode lasts longer than seven 
days (if untreated) at a time but it is still 
possible for the heart rate and rhythm  
to return to normal.
• Permanent or long-standing atrial 
fibrillation is present all the time and  
the heart does not return to a normal 
rhythm [30].
Symptoms, risk factors  
& treatment of AF
Not everyone who has AF will experience 
symptoms, but those who do can 
experience palpitations, dizziness, 
shortness of breath, tiredness or fatigue. 
Individuals who experience some of these 
symptoms are more likely to seek support 
from healthcare professionals and access 
treatment.
As many as 40% of people with AF do not 
experience symptoms (asymptomatic AF), 
however, their risk of stroke is unchanged[31].
The exact cause of AF is unknown, but it’s 
more common in men and risk increases 
with age.  A number of risk factors are 
associated with AF, including:
• high blood pressure
• heart failure
• valvular heart disease 
• previous heart attack 
• thyroid disease
• diabetes 
• chronic lung disease
• sleep apnoea
• kidney disease
• excessive alcohol consumption
• obesity
• smoking
AF is a treatable condition.  Treating AF is 
extremely important, especially to reduce 
risk of stroke. Treatment can include 
medication to help control the heart 
rate or rhythm or to help reduce stroke 
by preventing blood clots. Traditionally 
warfarin would have been prescribed but 
there are a range of newer anticoagulants. 
Other treatments include cardioversion 
to restore normal rhythm by delivering 
a controlled electric shock. Or catheter 
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ablation, during which the part of the heart 
causing the abnormal rhythm is destroyed 
by radiofrequency, after which sometimes  
a pacemaker is needed [30].
The understanding of stroke risk factors  
and ensuring appropriate treatment of AF 
allows for allows for significant reduction  
in the potential impact of AF.
Scale of AF  
in Northern Ireland
Atrial Fibrillation (AF) is the most common 
sustained cardiac arrhythmia, occurring 
in approximately 2% of the general 
population[6]. In Northern Ireland the overall 
prevalence is 2.0% of the population[16] 2018 
data (collected from GP practices), this 
has increased from 1.2% in 2008. Recent 
research has demonstrated that based on 
population data the estimated prevalence 
of AF is 2.5% in the UK[29]. This would suggest 
in Northern Ireland, with prevalence rate 
of about 2.0%, that approximately 80% of 
people with AF are currently being detected. 
Nearly 40,000 people in Northern Ireland 
are diagnosed with AF but it could be as 
many as 50,000 people with the condition 
due to the undiagnosed proportion. 
The impact of AF - Stroke
The human cost:
It is estimated that between 30-40% of 
individuals with AF may not be aware that 
they have it and the first manifestation of  
AF may be an ischaemic stroke[17]. AF is  
a major contributor to stroke incidence  
and a powerful predictor of first ever 
ischaemic stroke[10]. Approximately 25% 
of ischaemic strokes are thought to occur 
because of AF. It is generally accepted that 
these strokes tend to be more extensive, 
carry a higher mortality and increased 
morbidity[6]. Having untreated AF means 
that you may be five times more likely to 
suffer from a stroke than someone without 
AF, as well as contributing to a range of other 
conditions, including congested heart failure, 
cognitive impairment, decreased quality of 
life and mortality[17,24]. 
Stroke is the third biggest cause of death 
in Northern Ireland. It is estimated that 
AF causes 12,500 strokes in the UK every 
year, that potentially 7,000 strokes and 
2,000 premature deaths could be avoided 
every year through effective detection and 
protection with anticoagulant drugs that 
prevent blood clots forming[1,7]. 
In Northern Ireland, 10% of high-risk AF 
patients are not anticoagulated.  Evidence 
shows, that optimally treating high-risk  
AF patients over three years can avoid  
210 strokes[12].
The cost to Health & Social Care:
In Northern Ireland there are 36,000  
stroke survivors, 2,800 people admitted  
to hospital every year with a diagnosis of 
stroke and approximately 1,000 stroke 
related deaths. 
The economic cost:
In 2015, the average societal cost of stroke 
per person (UK) was £45,409 in the first 
12 months after stroke plus up to £24,778 
in subsequent years.   UK leading experts 
have recommended that there is a potential 
£4 billion saving to societal costs of stroke 
by 2035 through investment in improved 
stroke prevention[5, 15,18]. The cost of caring 
for stroke in Northern Ireland is projected to 
rise from £484 million in 2015 to £1.51 billion 
in 2035 with £585 million of this being health 
and social care.
One of the clearest ways of 
preventing a stroke is the detection 
and management of underlying 
conditions such as AF.
The growing problem ….   
AF and ageing population
UK population projections suggest that 
between 2015 and 2035 the total population 
aged 45 and over will rise by 22.5%[13]. Age 
is a risk factor for AF, the prevalence of 
AF roughly doubles with each advancing 
decade of age[1]. By 2030, the population  
in Northern Ireland aged 65-84 will rise  
by 37% and those over 85 by 76%.
Considering the ageing population, with 
people living longer it is essential that  
stroke prevention and management 
of underlying conditions such as AF is 
prioritised, to decrease potential stroke risk. 
The Policy Context
The need of reform and innovation  
within the health and social care sector  
is well documented and numerous policy 
documents point to the need to focus 
health promotion, prevention and early 
detection measures.
Transforming Your Care (TYC)
Published in December 2011 the TYC  
Review proposed a new model of care  
for Northern Ireland with the individual  
at the centre to improve the health  
and wellbeing of people by
• promoting good health decisions,
• preventing ill health in the first place,
• achieving better outcomes when ill  
health does occur and
• enabling people to live healthily and 
independently for as long as possible.
Health & Well-being 2026:   
Delivering Together 
Published in October 2016 Delivering 
Together further reinforces the message 
that change is essential and that,  
in particular, an ageing population presents 
challenges to services. It emphasises  
that advances in treatments, drugs,  
and technologies need to be adopted  
to counter every increasing need.
Delivering Together puts people at the 
forefront. The focus is on enabling  
people to stay well for longer.
Making Life Better – A Whole  
System Framework
The Northern Ireland’s Executive’s 
overarching public health strategy-Making 
Life better, was published online in June 2014. 
This framework’s vision is that “all people are 
enabled and supported in achieving their full 
health and wellbeing potential”. 
Stroke Services Review
The current review of strokes services 
focuses heavily on acute services and 
prevention is largely only considered with 
regard to transient ischaemic attack (TIA)  
or “mini stroke”.  NICHS believe we need  
a stronger focus on preventing strokes in  
the first place, to keep people healthy  
and out of hospital.
There are a number of other key public 
health policies and strategic drivers that 
have been taken into account. 
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CURRENT TREATMENT 
AND OUTCOMES
Quality Outcome Framework (QOF)
In Northern Ireland the overall prevalence 
 of AF is 1.9% of the population [16] 2018 
data, this has increased from 1.2% in 2008.  
This suggests that detection has improved, 
however, it is still lower than England where 
QOF data has a national prevalence of 2.0 
and many Clinical Commissioning Groups 
in the North West of England which have 
focused on AF detection have figures in the 
2.5-2.9 range.
Recent data for England has led to an 
estimated prevalence figure for England of 
2.5. Northern Ireland is unlikely to be hugely 
different, suggesting there is a considerable 
cohort of undetected AF. This would 
support the belief that there is a significant 
opportunity to increase detection and 
reduce stroke.
Total number of stroke and AF related strokes
Anticoagulation prior  
to stroke?
No. strokes No. AF 
strokes
% AF related 
strokes
Yes No
2017-18 2,774 520 18.9 360 101
2018-19 2,749 639 23 324 112
SSNAP Data
Sentinel Stroke National Audit Programme 
(SSNAP) SSNAP [20] is the national stroke 
audit which measures the quality and 
organisation of stroke care in the NHS.  
There are several elements of the audit  
data that are directly relevant to AF 
including number of AF related strokes 
and whether they were on anticoagulants 
prior to their stroke. The SSNAP regularly 
adds new questions and in 2018 the INR 
(International Normalising Ratio) range for 
individuals on Warfarin when admitted to 
hospital was added.
Data from the last two years has been 
analysed in order to give an indication  
of the current effect of AF related strokes.
This comparison shows that despite  
the total number of strokes falling, the 
number of strokes that were AF related  
has increased. The proportion % of strokes 
that were AF related has risen from 18.9%  
to 23% in 2018-2019. 
According to data collected by SSNAP 
between April 2018- March 2019, 149 people 
had a new diagnosis of AF following their 
stroke. This translates to 23.3% of all AF 
related strokes or 5% of all strokes in that 
year. From the SSNAP data above, there is  
a significant number of individuals having  
a stroke every year in Northern Ireland  
who didn’t know they had AF and who,  
had they been on appropriate 
anticoagulation, may have avoided  
having a stroke.
The most recent SSNAP data (April to 
September 2019) continues this trend  
with 24% of all strokes being AF related  
(up 1% since the year before) in this 
6-month period. Also, during this time  
64 people got a new diagnosis of AF 
following their stroke which corresponds  
to 19% of all AF related strokes.
Key points: 
In Northern Ireland 
• It is estimated at least 10,000 people remain undiagnosed.
• Analysis of two years of Sentinel Stroke National Audit 
Programme (SSNAP) data indicates, that despite the total 
number of strokes falling, the number of strokes that were  
AF related has increased from 18.9% to 23%.
• From SSNAP data, there is a significant number of individuals 
having a stroke every year in Northern Ireland who didn’t 
know they had AF and who, had they been on appropriate 
anticoagulation, may have avoided having a stroke.
• SSNAP data indicates the numbers of people with AF on 
appropriate medication for stroke prevention/anticoagulation 
and shows there has been improvements made – increasing 
from 60% in Apr 2016-March 2017 to 68%.  
• Over 30% of people with AF are not on appropriate medication.
• There are concerns about medicine management (adherence) 
as it is estimated that in the long term, 40-60% of people with 
AF may be non-adherent to their direct oral anticoagulant 
(DOAC) therapy.
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Management of AF related stroke
The SSNAP data allows us to see the 
numbers of people with AF on appropriate 
medication for stroke prevention/
anticoagulation. There appears to have 
been improvements made in this increasing 
from 60% in Apr 2016-March 2017 to 68% 
in Apr 2017- March 2018, but we can’t be 
complacent as this number fell slightly to 
66% in April 2018- March 2019. This trend 
is positive as anticoagulation is key to  
stroke prevention in AF patients.
However, this does leave over 30% of AF 
patients who may not be on appropriate 
medication. It is essential that patients with 
known AF are placed on anticoagulants 
where appropriate. There is a proportion  
of AF patients (63 patients) who are still  
on antiplatelet therapy only which is no 
longer recommended by NICE and is 
therefore not providing sufficient stroke 
prevention. This offers an opportunity  
to improve management of AF related  
stroke prevention.
It is not only critical that AF patients are  
put on an appropriate anticoagulation  
but, when they are prescribed Warfarin,  
that this is managed and within range, 
to be of stroke prevention benefit. 
From April 2018-March 2019 the INR range 
of all relevant AF patients could be recorded 
as part of the SSNAP database.  This related 
to 140 patients, 24 did not have their INR 
checked.  Of the patients who did, 48%  
(56 patients) had a value between 0-1.9; 
44% (51 patients) had a value of between 
2-3 and 8% (9 patients) who had a value 
over 3. The optimal range is an INR between 
2-3, this corresponds to 56% of all patients 
were not in range for correct and effective 
anticoagulation. 
This is a worrying trend and highlights issues 
around the management of Warfarin, which 
is particularly concerning as Warfarin clearly 
requires regular monitoring, and it  
is important that patients receive this.
In comparison to Warfarin, direct oral 
anticoagulants (DOACs) offer many 
treatment advantages, including fixed 
dosing, fewer drug and dietary interactions, 
rapid onset and short half-lives, which  
can preclude the need for peri-procedural 
bridging, as well as no monitoring 
requirement. 
It is also important to be aware of  
potential disadvantages: 
• there is no specific reversal agent  
(except for Idarucizumab for Dabigatran), 
• there is a need for avoidance or dose 
reduction in renal impairment and 
• the short half-lives necessitate  
strict adherence.  
This is of importance as the number of AF 
patients on DOACs in Northern Ireland is 
increasing in Apr 2018-March 2019 62%  
were on a DOAC compared to 36.7% of 
people on Warfarin.
Direct Oral Anti-Coagulant (DOAC) 
Adherence
Any medication regime is only as effective as 
the adherence to it. Warfarin prescription has 
an associated management regime which 
provides a means of adjusting dose and an 
opportunity to check and discuss adherence. 
One of the perceived advantages of  
DOACs is the removal of the need for this 
consistent monitoring, however this may 
lead to an issue around adherence. It has 
been suggested that in the long term  
40-60% of patients may be non-adherent  
to their DOAC therapy [2]. This lower 
adherence of DOAC is associated with 
increased risk of mortality and stroke [9].   
It is therefore important that adherence  
on DOACs is not neglected. 
There have been a number of studies  
and some prediction modelling to  
identify people with AF at risk of being 
non-adherent, these factors include longer 
time on the medication, younger age, male 
gender, asymptomatic disease and lack of 
understanding of nature of disease[3]. 
Recent studies suggest that adherence can 
be increased by: 
• Appropriate selection of DOAC therapy 
by involving the patient in the decision 
including dosing (daily v twice daily); 
• Patient education- regarding the 
importance and purpose of the DOAC 
including perceived risks and benefits; 
and
• Employing some ongoing patient 
monitoring face to face or via phone [21].
Warfarin:  
56% 
of all patients were not in range for  
correct and effective anticoagulation
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NICHS carried out a tendering process 
to appoint an independent researcher to 
undertake the inquiry.  Dr Niamh Kennedy 
was appointed in March 2019 and the 
inquiry research commenced in April 
2019 and concluded in January 2020.
An independent panel was then established 
to advise and assist the inquiry and three 
roundtable meetings were held to enable  
a broad range of people to contribute. 
NICHS invited stakeholders with relevant 
expertise to join an AF Inquiry Advisory 
Panel, together with a representative from 
NICHS and the independent researcher 
from Ulster University. We approached 
people living with AF to join the panel, 
however, they said they would prefer to 
share their experiences of living with AF  
in a more personal way. 
In addition to seeking the views of those 
through the survey questionnaire,  
Dr. Kennedy conducted one to one 
interviews with patients and professionals 
and Neil Johnston attended a number  
of our Stroke Group meetings across 
Northern Ireland to hear directly from  
our service users about their experiences. 
The Panel advised and assisted the inquiry, 
developed questionnaires, invited other 
colleagues to roundtable discussions to  
feed into the inquiry and reviewed this report.
Inquiry methodology
Over nine months, this extensive, 
independent inquiry carried out  
the following:
• Significant desk research was undertaken,  
A service user and a healthcare 
professional questionnaire were 
circulated and analysed (between  
May and October 2019) 
• 18 one to one interview with patients and 
healthcare professionals were carried  
out between March and October 2019.
• Three roundtables (between May 
and October 2019). The roundtables 
included clinicians from across the 
whole clinical pathway with a range of 
expertise, representation from Northern 
Ireland Chest, Heart and Stroke (NICHS), 
representatives from local political 
parties and from pharmaceutical 
companies involved in providing 
medicines related to AF.  The views  
and opinions collated from service 
users and the results of the surveys were 
extensively discussed at the roundtables. 
The information gathered from all 
this was developed into themes 
from which the recommendations 
were derived. The following chapters 
provide a more detailed breakdown. 
Public Awareness of AF 
In parallel to the inquiry process, NICHS 
ran a public awareness campaign and 
commissioned two independent opinion 
surveys in October 2018 and October  
2019 - one pre and one post poll to  
measure campaign activity and impact. 
The polling was done by Cognisense 
(previously known as Ulster Marketing 
Surveys, and later Kantar Millward Brown 
Ulster), a well-established and respected 
polling company, using a representative 
sample of 1,000 responses from across 
Northern Ireland.
Key points:
• Pre-campaign public  
awareness – only 30%  
had heard of AF.
• Awareness of AF has risen  
markedly from 30% last  
year to 37% this year 
• 50-64 age category  
had a larger increase  
in awareness - 11%.
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Pre-Public Awareness  
Campaign polling:
The pre-campaign polling took place in 
October 2018.  The Poll identified, that only 
30% of the people had heard of AF and, 
more worryingly, only 30 people out of 
a sample of 1,000 (3%), knew that it can 
increase your risk of stroke by five times. 
Of the 30% who have heard of AF:  
• Over a quarter didn’t know about  
the increased risk of stroke 
• Nearly 10% thought AF does not  
increase your risk of stroke. 
It is anticipated that greater 
awareness could led to better 
understanding of potential 
symptoms, discussions with health 
care professionals and improved 
rates of AF detection in the 
undiagnosed population.
The Awareness campaign:
NICHS embarked on a modest public 
awareness campaign to raise awareness 
of AF and its link with stroke in Spring 2019 
using billboards and bus shelter ads, radio 
ads, posters in GP surgeries, pharmacies 
and libraries. The campaign was supported 
by local retailer, Mace, who displayed 
posters in their stores, included AF 
information on the leaflets they sent  
out to the public, and organised AF testing 
for customers in selected stores. NICHS 
then commissioned a second opinion poll, 
in October 2019 to measure the impact of 
this awareness campaign.
Post campaign public opinion poll results:
NICHS commissioned a second opinion awareness poll in October 2019 after the campaign 
had completed.
We compared the results of the pre and post polls to identify if there had been an impact
Have you ever heard of a common heart rhythm  
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Did you know?Over 37,000 people in NI are living with AF although it is estimated that many more are living with the condition undetected, which  is why you need to  get checked.
What is AF?
Atrial Fibrillation (AF) is a type  
of irregular heartbeat.If you have AF, your heart will  
not have a regular beat and may  
be abnormally fast. The heart  
may not empty its chambers  
of blood at each beat and a clot 
can form in blood left behind, 
which can then travel to the  brain and cause a stroke.
What are the health risks associated  with AF?
   •  Almost double the death  rate from stroke
•  Increased disability  from stroke
• Longer stay in hospital•  Increased risk of a stroke  happening again 
Atrial fibrillation makes your risk  of a stroke five  times higher.
Healthy Lifestyle & SupportHaving a good quality of life is an important goal if you have AF.  
In addition to taking your medication, you should aim to have  
a healthy lifestyle which you should discuss with your doctor.
Watch your weight




Moderate your  alcohol intake Manage your stress levels
Get enough sleep
Further SupportIf you would like further support in managing your AF please 
contact us about our ‘Taking Control’ Self Management 




Medication Your doctor may prescribe medicines to control the 
rate and rhythm of your heartbeat
2
Cardio-versionElectrical signals are sent to your heart through 
electrodes placed on the chest.
3
Ablation
The use of heat or freezing on the area of your heart  
that’s causing the abnormal heart rhythm
Potential treatments for the symptoms of AF:
Testing for an irregular heartbeat during our health check
The percentage of people who have heard  
of AF has risen from 30% last year to 37%  
this year. 
The most significant increase has been in 
the 50-64 age category which saw a 31.4% 
increase in awareness. This is particularly 
welcome given the close relationship 
between the increasing prevalence of AF, 
age and stroke risk.
Raising awareness of a complex medical 
term such as AF represents a considerable 
communications challenge however the 
relatively modest campaign by NICHS 
appears to have had some success.
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The results in terms of projecting the 
message about the fact that AF can  
increase the risk of stroke by 5 times  
are less clear cut. The numbers replying 
Don’t Know to this proposition  
increased markedly. 
The awareness campaign did halve (from 
8% to 4%) the numbers of people who  
were unaware of any stroke risk - this was 
entirely due to a significant fall from 10%  
to 2% amongst women. The numbers 
who were correctly aware of the level of 
stroke risk was unchanged. Those thinking 
AF doubled your risk reduced while those 
thinking it trebled your risk increased.
Feelings about diagnosis
When respondents were asked if there was anything they would like to share about their 
experience of being diagnosed with AF, a few themes emerged.
Theme Example quote
Shock and fear • “it was a horrible feeling to be told I had AF, I felt I had done 
everything right. I was fit and healthy, this had a big impact  
on my mental health”
• “it was a shock, I was young and healthy”
Stroke • “I was only diagnosed after my stroke, it was a huge shock that 
my stroke could have been prevented”
It is possible that the wording of the 
question may have influenced the 
responses e.g. perhaps there were too 
many options, and maybe a binary choice 
– “does AF increase your risk of stroke?” 
would have been more appropriate.
In short, overall awareness of AF has 
increased markedly, however, amongst 
those who are aware of the condition, the 
message about the level of risk involved 
may not have been understood. The results 
do show that a relatively modest public 
awareness campaign can have a significant 
impact on public knowledge with potential 
public health benefits.
AF and risk of stroke 
Subset: only people who knew what AF was. 
Having the heart rhythm 
condi-tion AF (Atrial 
Fibrillation) can…?
2018 2019 Change in % 
points
% Change
Double your risk of having  
a stroke
40% 35% ↓ 5 ↓ 12.5
Triple your risk… 14% 16% ↑ 2 ↑ 14.3
Increase your risk… by 5 times 11% 11% No change 0
Does not increase your risk 8% 4% ↓ 4 ↓ 50
Don’t know 27% 35% ↑ 8 ↑ 29.6
The Questionnaire  
Survey Results
Two questionnaire surveys were 
designed and issued: one for service 
users, and the other for healthcare 
professionals. These were sent out 
in May 2019 and remained open until 
October 2019.
Service User Survey: Engaging  
with people living with AF 
This survey consisted of 14 questions  
about living with the condition of AF, 
including questions about diagnosis, 
information and knowledge about their AF, 
and any other comments they had. 
There were 40 respondents, 52% female 
and 48% male with year of births between 
1929 and 1973, from across Northern 
Ireland. Respondents were diagnosed  
with AF between 1995 and 2019, with  
2018 being the most popular answer.
Who diagnosed you with AF?
• GP - 37.93%
• Cardiologist  
(heart doctor) - 34.48%
• Stroke doctor - 10.34%
• Other (A&E doctor, NICHS,  
thyroid doctor) - 17.24%
Overall awareness of AF increased markedly,  
however, amongst those who were aware of  
the condition, the message about the level  
of risk involved may nothave been understood.
Key points:
• Nearly 38% of people with AF were 
diagnosed by the GP.
• Two out of five people received a brief 
description to inform them of their 
condition.
• Lack of equality and standardisation  
in information on AF.
• Over 50% had a good understanding  
of their condition. 
• When diagnosed, there is great  
support – with over two thirds of  
people felt their care and treatment  
was good or very good.
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Information • “I would have liked more information”
Other • “I had to wait a long time for my appointment with cardiologist  
and for my tests- echo etc.”




• 67% of HCPs do not believe  
there is an effective care 
pathway for AF.
• Just under one third (31%)  
of respondents stated they  
used a pulse check as a method 
to diagnose AF.
• 86% of HCP respondents  
stated there should be AF 
screening programme.
• Over half (58%) of respondents 
believed AF should be managed  
by a GP.
• 40% of respondents identified 
the lack of resources as 
significant challenge to 
treatment and care for people 
living with AF. 
• Over one quarter (26%) of 
respondents viewed patient 
adherence as a challenge in the 
treatment and care of AF.
Background:
This survey consisted of 15 questions  
on AF in Northern Ireland, including the 
profession of the respondent and questions 
on methods of diagnosis, barriers to 
diagnosis, AF screening programme and 
management of AF.  
Over 100 healthcare professionals  

























The most common form of information 
given was “a brief description”, with two 
in five people stating it was the main 
source of information.   This may not be 
sufficient enough detail to ensure patient 
understanding and adherence. The other 
answers included an “appointment with 
cardiologist” or “other consultant”.
When the respondents were asked to tell  
us more about the information they 
received, it was polarised between people 
who felt they received a lot of information 
and other who felt they didn’t get enough.
The following examples illustrate the 
different experiences of service users. 
Sufficient information:
• “Helpful video of explanation of AF.  
Full explanation from nurse on diagnosis. 
Management of symptoms”
• “Detailed explanation of condition. 
Information leaflets helpful!”
Needed more information
• “I googled it after I always felt I needed 
more information”
• “Would have liked more info and support”
• “felt I was told in a very brief manner, 
lacking in detail”
This demonstrates the lack of equality and 
standardisation in the information type and 
detail that AF patients are receiving.
Treatment and support
The findings were very positive:
• Over 50% of respondents felt they had  
a good understanding of their condition. 
• Over two thirds of people felt their care 
and treatment was good or very good.
• Over 95% of respondents had  
a further appointment with a health  
care professional after their initial  
AF diagnosis.
In addition, the majority had ongoing care 
from their GP with input from practice 
pharmacists, practice and specialised 
nurses. A proportion still received input 
from their cardiologist, which is in keeping 
with the NICE guidelines.
The survey finished with asking AF patients, 
if there was anything else you would like 
to tell us about that could have improved 
your diagnosis or living with AF? Comments 
ranged and included:
• “I had never heard of AF and now I’m left 
with effects from my stroke and if my AF 
had been detected I would never have 
had my stroke” (MALE, 76, Dungannon)
• “I didn’t know the condition existed before 
I got diagnosed” (MALE, 59, Bangor)
• “I took control of my life, health and AF. 
But it effected my head, I felt really shook 
by it” (MALE, 66, Belfast)
• “more time to understand the drugs, felt  
I was just scared about stroke risk” (MALE, 
77, Belfast)
• “don’t like the feeling that AF caused my 
stroke and that it could cause another 
one”. (FEMALE, 65, Newtownards)
These quotes demonstrate again the  
shock that AF patients can feel, the lack  
of public understanding and the need for 
more information. 
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Key findings:
Do you think Northern Ireland has effective pathways for diagnosis of AF?
HCPs recommend:
When asked to provide additional comments, the following key themes and comments 
were identified by HCP respondents: 
Theme Example quote
Need for screening “Opportunistic screening programme- target over a certain age  
or at other clinics”
“could use existing clinics to screen”
“insufficient opportunistic screening and poor searching for AF”
Monitoring “Should monitor high risk patients”
“people get lost, monitoring needs to get better”
67% of respondents felt 
Northern Ireland did not 
have an effective pathway 
for diagnosis of AF. 
Current issues “Currently leaves too much to chance”
“works in part but still needs improvement”
Resources “Could be catching more AF if had the resources”
“not enough investment so pathway is slow”
Stroke “still a major contributing factor I see on admission to the  
stroke ward”
“Still too many people finding out about their AF when they  
have a stroke”
Diagnosing AF:
Respondents were asked a number of questions regarding diagnosing AF. The following  
was identified:






























































3% 3% 3% 3%
11%
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What is your profession? (%)
GP
67.4%
   Yes
   No
32.6%













All GPs reported using pulse checks, in 
combination with additional measures. The 
most common of which was 12 Lead ECG 
which 66% (25 GPs) used while 42% (16 GPs) 
used single lead ECG. Holter monitors were 
also common with 32% (12 GPs) using them, 
and 2 GPs mentioned the use of Kardia 
devices. Highlighting although GPs primarily 
appear to use pulse checks all of them apart 
from one used ECG (either single lead or  
12 lead) as well, suggesting access to ECG  
is high in this GP sample.
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Risk Factors Target people with known risk factors.
High risk patients monitored
Opportunistic screening over 65
Use patient database to identify potential sufferers
Public Education Using apple watches etc. for people to gain understanding of AF
More understanding of AF as a condition
Resources Include in the GP contract.
Could be GP LES where patients have annual pulse and BP check
 

















When asked what resources would be useful in explaining the condition at diagnosis:
• 32% recommended using a leaflet to  
help explain AF at the point of diagnosis
• 30% recommended a specialist nurse or 
practice pharmacist as a key source for 
information at the point of diagnosis 
Treatment and management of AF








What are the practical barriers to diagnosing Atrial Fibrillation?
   No ECG
   No symptoms to suggets checking pulse
   No screening tools or pathway
   No resources for screening






• Just over a third (34%) of respondents 
stated the barrier to diagnosing AF was 
the lack of resources, this was following by 
32% stating there was no screening tools 
or pathway for AF
• Answers for others include time, high 
workload, public understanding, ECGs are 
time consuming for treatment rooms, not 
part of GP contract, improper GP referral.
Do you think there should be Atrial Fibrillation Screening programme?
• 86% of HCP respondents stated there 
should be some type of AF targeted  
detection programme.
• When asked to identify possible actions 
to address key issues concerning 
diagnosis, HCPs suggested the following 
(see table):
Theme Example quote/detail
Pulse Checks Pulse checks (annual for those over 55; annual reviews,  
target individuals)
Technology Use of technology (iPhone, handheld devices)
Outside GP Pharmacies offer pulse check as well as BP testing. Use practice 
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• 40% of respondents identified the lack 
of resources as significant challenge to 
treatment and care for people living with 
AF, followed by 32% recognised waiting 
times as a challenge. 
• Over one quarter (26%) of respondents 
viewed patient adherence as a challenge 
in treatment and care of AF
The other answers included a variety of answers including:
• no review; 
• pharmacist review; 
• annual review of bloods etc.; 
• referred to GP; 
• referred to cardiology.





0% answered  
“stroke physician”
   GP
   Cardilogist
   Arrhytmia Nurse
   Other
Over half (58%) of respondents believed AF 
should be managed by a GP
The survey finished by asking if there were 
any other comments about the diagnosing 
and treatment of AF in Northern Ireland they 
would like to add. 
Additional comments included:
• “Requires innovative digital solutions 
integrated into the clinical pathway for 
diagnosis and monitoring.” (Cardiologist)
• “Large number of patients on stroke 
wards have undiagnosed AF, this is an 
important and relatively easy way of 
potentially reducing stroke incidence 
 and cost.” (Stroke Physician)
• “Need to improve patient understanding 
and public awareness to ensure 
individuals realise how serious this 
condition is and therefore improve 
adherence.” (Practice Pharmacist)
• “Patient understanding and adherence  
to NOACs problematic, people were more 
scared of Warfarin and its consequences.” 
(Practice Pharmacist)
• “Pharmacists have a key role in identifying 
patients who are poorly controlled on 
Warfarin who should be switched to  
a NOAC and we should be taking a 
proactive role in this. This should help 
reduce the devastation strokes can  
cause to patients and their families by  
this condition.” (Practice Pharmacist)
• “Need more joined up working between 
GP and cardiology.” (GP)
• “Long waiting lists to be seen.”  
(GP and cardiologist)
Key points:
• Panel members, health care professionals 
and patients agreed that not enough  
is currently being done to identify the 
large number of people with AF who  
are undiagnosed.
• Widespread, whole population screening 
programme was not cost effective or 
practical.  However, it was felt AF has clear 
risk factors (assessed by CHADSVASC), 
that targeting of those individuals would 
be beneficial. 
• There needs to be a more systematic 
way of detecting AF, using opportunities 
to identify at-risk patients, for example at 
flu clinics, diabetic reviews, hypertension, 
COPD clinic and health checks or 
medication reviews.
• Need to share best practice and 
innovation within a pathway.
• Need to provide education and upskilling 
to GPs (and others in primary care) about 
AF and AF pathway. 
• Service users living with an AF diagnosis 
may not fully understand their condition 
which has an influence on how they 
manage their condition.
• Waiting lists for echocardiograms have 
doubled from approximately 10,000 in 
2016 to 20,000 in 2019.  
• With a 16 fold increase (1570% over the 
three year period (Sept 2016-Sept 2019) 
of patients waiting over 26 weeks for  
an echocardiogram there is potential 
for delays in diagnosis and treatment to 
impact negatively on patient outcomes. 
 
Three roundtables were held between May and 
October 2019 in NICHS Head Office in Belfast.  
Attempts were made to ensure as many HCPs  
and participants could attend by varying the day  
it was held on to account for outpatient clinics, etc.  
There were approximately ten participants at each 
of the roundtables these included cardiologist, 
General Practitioners, pharmacists (both practice 
and hospital based), Assistant Director of Promoting 
Health & Wellbeing, a cardiac nurse, representation 
from local political parties, representation from 
pharmacological companies involved in AF 
medication, representation from a local medical  
auditing company, representation from NICHS  
(who ensured the service user perspective was  
part of the discussions) and the lead researcher.
Key conclusions
The need for effective pathway for  
diagnosis was overwhelming supported  
by the clinicians. Equally there was strong 
support for some form of targeted screening 
or process for identifying AF amongst at risk 
cohorts of the population. 
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The Roundtable meetings discussed,  
and analysed information and data 
collected from the engagement phase. 
This included feedback from service 
users, patient and healthcare survey 
results. They also raised issues and 
solutions from their perspective.  
All of this information was grouped  
by the researcher thematically. 
Theme 1: Need for targeted 
detection to identify 
undiagnosed AF
The most common theme to be discussed 
during the roundtables was detection.  
Participants discussed the advantages  
and pitfalls of targeted testing programmes, 
how we might identify the large number 
of undiagnosed patients and specific 
examples of detection. It was widely agreed 
that not enough is currently being done to 
KEY THEMES FROM  
THE INQUIRY RESEARCH 
identify the large number of people with  
AF who are undiagnosed but it was felt that  
a whole population screening programme 
was not cost effective or practical. 
However, it was felt AF has clear risk factors 
(assessed by CHADSVASC), that targeting  
of those individuals would be beneficial. 
It was felt that using the term detection 
opposed to screening was useful, as  
not only is screening not advised in the 
current NICE guidelines but it also more 
accurately represents the identification  
of these patients.
It was also felt that all potential opportunities 
should be used to identify these at-risk 
patients, including Flu clinics, Diabetic 
reviews, Hypertension, COPD clinic and 
health checks or medication reviews. This  
is an effective way of reaching patients and 
due to technology (AF detection devices) 
can be tested in a time efficient way.
Theme 2: Need for Good 
Practice and Innovation
The second most common theme to be 
discussed during the roundtables was good 
practice and innovation.  Members shared 
good practice either within current services 
or from elsewhere. 
An overview of different types of innovation 
and good practice are provided in the case 
studies below:
Example1: South Eastern Health  
& Social Care Trust - Pilot Community 
Pharmacy Offer 
In the SEHSCT area, a pilot Community 
Pharmacy Hypertension Detection Service 
was developed by the SE Integrated Care 
Partnership. Patients can have a robust HBP 
test (including a week’s testing via a home 
monitor), be given lifestyle advice, and be 
signposted to community services by their 
local Community Pharmacy. This potentially 
achieves improved detection rates while 
reducing ‘false’ high readings due to white 
coat syndrome. 
In the context of the new ICP / Community 
Pharmacy pilot, a complimentary initial 
detection pilot was undertaken, alongside 
the Pharmacy pilot in one geographical 
locality within the SE area (Lisburn). This 
initial pilot was intended to drive additional 
high-risk individuals to their local pharmacy, 
who otherwise would not visit either their 
local Pharmacy or GP on a regular basis.  
This initial detection pilot was delivered  
by NI Chest, Heart and Stroke (CHS). 
The initial detection pilot involved  
a rolling programme of pop-up testing  
over a 6-month period building on NICHS’s 
innovative Health Checks Pop Up service 
across NI. Both HBP and AF testing were 
offered. These pop-up tests took place  
at community locations where there are 
large numbers of people across Lisburn  
over two days per week. 
These included:
• Large workplaces in Lisburn including 
Lisburn Health Centre, Lagan Valley 
Hospital, PSNI, NIFRS HQ and Lisburn 
Castlereagh City Council e.g. canteens
• Shopping Centres including Bow Street 
Mall and Sprucefield
• Transport Hubs, including Bus and  
Train stations
• Parks, such as Wallace Park and local 
events such as park Runs
The tests were intended to be focused on 
the over 45 population and were carried out 
using ‘pop-up’ cubicles, which individuals 
were able to either drop-in or pre-book  
on-line. Community groups were also able 
to request ‘group testing’ at community 
clubs and events. A key role for the staff 
delivering the checks was to engage with the 
passing public, to encourage them to get 
tested, and to identify the other potential 
locations and times to engage with the 
target population.
Between July and December 2019, a total 
of 1,826 checks were carried out, this 
resulted in 51 patients being identified with 
AF – of who, 28 were new referrals.  This is 
28 individuals who potentially may need 
anticoagulation and can work with their GP 
to hopefully prevent stroke.
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AF Referral Age Breakdown SET Project 
18-44 years old - 15 
45-59 years old - 11 
60+ - 25
In addition, 441 people were referred to  
their GP and 58 to their pharmacist 
regarding high blood pressure. 220 were  
new referrals. (10 individuals were referred 
for both AF and high blood pressure).
It is an important to consider two potential 
limitations to this. Firstly, that it is up to the 
individual what they do with the information 
provided by this check, not all patients 
may act upon it and see their GP. Secondly, 
there is potential to increase strain on GP 
practices by sending more patients to see 
them. But the numbers identified are not 
huge and are spread throughout the South 
East region. 
As outlined within the case studies,  
the possibilities to prevent strokes 
through combined AF and blood pressure 
checking are obviously substantial and 
are worth further exploration. 
Example 2: Well Check 
NICHS Well Check
NICHS runs health checks throughout 
Northern Ireland in places of work, at  
public places or events. Our health checks 
aim to detect the early warning signs 
associated with developing chest, heart  
and stroke conditions.
Our health promotion team offer a range 
of health checks that assesses lifestyle, 
blood pressure (B), cholesterol (C), BMI 
and others. Last year, NICHS introduced AF 
(A) testing to the well check measured via 
Alivecor NICE approved technology, which  
is a simple test that only takes five minutes 
yet can help prevent AF related strokes.  
 If someone is classified as having AF, they 
are advised to go to their GP, given an NICHS 
client leaflet about AF and are emailed their 
ECG results from the Alivecor with a further 
reminder to go to their GP. The following 
week they are sent their full health report 
with a further reminder to see their GP if 
AF detected and to contact the NICHS 
health promotion team for advice and 
support. Clients are also informed about, 
and encouraged to attend, NICHS Support 
Services, including our Taking Control Self 
-Management 6- week programme.
NICHS is the only local charity offering  
a comprehensive ‘ABC’ Health Check  
in Northern Ireland. 
We offer a range of health checks that  
are based on NICE approved guidelines  
with same day results provided, these 
include our:
• AF and BP check
• ABC Health Check
• Full Health Check that assesses ABC, 
Body Composition, Blood Sugar,  
Lung Capacity, Lifestyle with advice  
and goal setting.
At the Balmoral Show in 2019,  
1,061 AF checks were carried out  
and 23 individuals were signposted  
to their GP
In addition, from January - December 
2019, 4,660 AF checks were carried  
out and 148 individuals were  
signposted to their GP
Example 3: Cardiac Nurse Led AF Clinic 
AF Clinic 
An innovation developed in SEHSCT has 
been the development of an AF specific 
clinic run by a specialised cardiac nurse. 
People newly diagnosed with AF are  
referred direct from local hospital 
(emergency department or elderly care)  
or from cardiologist. The service involves  
an extended appointment time (45 
minutes) to provide enhanced patient 
education and counselling.  
This appointment time is substantially 
higher than the average GP appointment 
(10 minutes) or practice pharmacist 
(15-20minutes). This longer appointment 
time allows for more detailed discussion  
of anticoagulation options, counselling 
around these options and patient  
education of the risks of AF. 
Service users will also be reviewed for their 
suitability for cardioversion.  In addition, 
service users are then reviewed 4 weeks  
later to answer any further questions  
and a patient education ‘top-up’. They  
are then refereed back to their GP to 
reviewed annually. 
It is hoped that this initiative helps improve 
adherence due to additional time for  
patient education/counselling and will 
practically help to address long waiting  
lists in cardiology.
Theme 3: Resources  
and budget 
In the current economic climate and  
with the associated funding restrictions 
on Health & Social Care, the ongoing issue 
of cost and resource was raised. Several 
participants gave examples of how external 
money (from outside NHS) for example, 
from pharmaceutical company medical 
education grants, were used to audit GP 
registers to identify patients with key risk 
factors of AF and to call them in for review. 
Funding for an independent company  
to carry out targeted detection was 
regarded as worthy of consideration,  
as this addressed both a funding and 
capacity issue within GP practices. 
There was also discussion regarding the 
cost of various treatments, specifically 
anticoagulants and the relative cost savings 
that may be generated by switching.  
The cheaper up front/daily dose of Warfarin 
compared to direct oral anticoagulants 
(DOACs) versus the ongoing monitoring 
costs associated with Warfarin was noted.
“Very thorough examination, good explanation  
of results and follow up actions.”
“I was grateful for the health check because,  
unknown to me, I had high blood pressure and  
had no idea. So as a result of that, I have had to  
be monitored at the doctor for about 3 months.”
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Theme 4: Awareness and 
Understanding
In terms of awareness, many participants 
discussed the lack of public information 
and awareness on AF – specifically 
understanding what the condition is; 
what are the risk factors and what are the 
potential complications and consequences 
of AF. It was felt there was a body of work to 
be done raising public awareness  
of this condition and related complications.  
Various examples were discussed – such 
as diabetes and hypertension and blood 
pressure. The latter examples are useful 
when exploring how best to increase  
early detection. 
As highlighted within research carried out 
both before and after the public awareness 
campaign, even when people knew what AF 
is, the message about being at greater risk 
of developing a stroke is lost as many felt it 
is something that only affects older people 
and is therefore not relevant to them.  
 It is imperative that people are provided 
with similar information and education as 
people living with diabetes have access. 
Those living with diabetes are at a similar 
risk of stroke as people living with diabetes.  
Theme 5: Promoting  
self-management and 
medicine compliance
In terms of secondary prevention / self- 
management and education, roundtable 
participants discussed how service users 
already diagnosed with AF needed additional 
support, education and self-management.  
Earlier detection and diagnosis combined 
with education and support will aid medicine 
management and ultimately reduce the risk 
of a major stroke.  
Adherence to medication was identified  
as a major concern. Evidence suggests  
a crucial part of managing AF is  
compliance, as failure of the patient to  
take their prescribed medication will  
reduce the effectiveness in stroke 
prevention [4].This issue was raised in 
roundtable discussions.  
Pharmacists highlighted how enhanced 
patient understanding and education 
(possible through longer appointment time, 
increased education/counselling) could 
improve compliance. It was recommended 
that there should be a more co-ordinated 
approach to management and education.  
In addition, several AF patients mentioned 
how isolating it was, citing the impact of 
lack of information of their condition.  
Service users highlighted how valuable 
peer support from fellow AF patients could 
be. It was suggested at the roundtables 
that patient support networks could also 
improve medicine management.
Theme 6: Issues in current  
AF pathway
There were several key areas highlighted 
within the current pathway that are affecting 
current AF care and management.  This 
was further supported by feedback from 
the Healthcare Professional questionnaire 
findings, which also identified lack of 
resources (cost, staff and capacity) as 
creating barriers and challenges to providing 
a more consistent approach to the effective 
management of AF in Northern Ireland.   
This was specifically evident with responses 
from GPs, who stated they did not have 
sufficient time with patients to explain the 
condition and treatment options.  
This was further supported by service users 
who outlined that they didn’t have enough 
time in appointments to understand their 
condition and treatment. 

























iography 9968 12,323 12,886 13,288 12,648 13,154 15,929 17,131 17,114 17,296 19,363
20,042
(Over 26 weeks) 540 1,466 2,447 3,406 3,338 3,869 5,686 7,073 6,997 6,810 8,721 9,019
             
First Inpatient  
Appt 
(admission)
            
Cardiology 2,833 2,704 2,600 2,592 2,587 2,493 2,285 2,354 2,196 2,122 2,199 2,119
Over 52 weeks 8 57 130 243 349 237 90 82 73 74 124 70
26-52 weeks 452 576 606 616 482 380 323 456 330 328 310 279
             
Outpatient             
first consultant 
led appt 7,906 8,074 8,519 8,394 8,770 7,772 8,240 9,104 9,767
10,304 10,531 10,832
Over 52 weeks 236 522 710 938 1,146 232 221 319 263 351 651 834
18-52 weeks 2,387 1,903 2,104 2,339 2,418 1,934 1,749 2,436 2,603 2,582 2,835 3,206
Theme 7: Waiting Lists
Waiting lists for echocardiograms have 
doubled from approximately 10,000 in  
2016 to 20,000 in 2019.
This is a problem that has been building  
for a considerable period. Some may argue  
that it has been driven by increaseddemand 
due to both increased awareness of AF and 
the rapidly increasing elderlypopulation.  
It should be noted, however, that the increase 
in elderly population has been long predicted 
and it should have been possible to prepare 
to meet this demand through additional 
recruitment of relevant staff. 
Funds were put in place to recruit 5 
additional WTE clinical physiologists in 
2018. Regardless of whether this individual 
initiative was successful or not it is clear  
that it has little to no impact on the waiting 
list situation.
The number of patients waiting over 26 
weeks for an echocardiogram has gone 
from 540 in September 2016 to 9,019  
in September 2019. This represents  
a sixteen-fold (1570%) increase over the 
three-year period. Clearly there is potential 
for delays in diagnosis and treatment to 
impact negatively on patient outcomes.
Theme 8: Technology
Both the HCP Questionnaire and the 
roundtable discussed and viewed the 
variety and ease of AF detection devices  
as a widely positive development.
1. Technology which is used by healthcare 
professionals for example NICE approved 
devices such as the AliveCor
2. Technology which is used by service users 
– for example widely used devices for 
smart phones or fitness trackers.  
Conclusions
To summarise, the collective information gathered from  
extensive engagement with service users and healthcare 
professionals, indicates that there are clear gaps in  
understanding, detection and management of AF in  
Northern Ireland. It can be seen from the SSNAP and  
other data that there are still a significant number of  
individuals who are only being diagnosed with AF following  
their stroke and others who have had a stroke, and were  
not receiving anti coagulation, despite have been previously 
diagnosed with AF.
The recommendations suggested in the next section  
of this report will help shape discussions on the way  
forward in helping provide a high-quality service for  
people living with AF in Northern Ireland.  
The implementation of these handheld 
devices into GP practices has allowed  
for other healthcare professionals to 
conduct screening and is seen as  
a quick tool. 
Discussions recommended further 
investment in the use of proven 
technologies within clinical practice  
to detect AF.




I could  
have  
a stroke”
Meet Rosaleen Fearon from Newry. 
Rosaleen was lucky as her atrial 
fibrillation (AF) was diagnosed when  
she was admitted to hospital to  
received treatment for a fractured back. 
 “I didn’t understand at the time. I remember the nurse 
taking my pulse and saying the doctor will probably want 
to have a chat with you about your heart.  I didn’t take this 
diagnosis serious at all and just continued life as normal 
thinking I was healthy.”
 “I was put on medication and was told to take 2 Apixaban 
tablets per day.  Unfortunately, a friend told me she didn’t 
bother with the two tablets and I had heard others saying 
this too, so I just took one of them instead of both.”
 Rosaleen didn’t understand the seriousness of the condition 
and didn’t understand the importance of taking her blood 
thinning medication.  Then tragedy struck in June 2018. 
 “I don’t remember very much about the day I took my 
stroke.  I was making the bed and thought I’d tripped  
over the pillowcases, but I ‘d collapsed.  The next thing  
I remember is waking up in the Royal Victoria Hospital  
and being told I’d had clot retrieval surgery.”
 “I didn’t know it was possible I could have a stroke because 
of AF but I remember the GP telling me quite firmly that  
the second tablet would have helped prevent the stroke.”
 Rosaleen believes strongly in playing an important role 
in her care and is a great champion for awareness and 
education.  Since her stroke, she has completed NICHS’ 
Post Rehabilitation Exercise Programme (PREP). 
 “Talking to others with the same problems has really  
helped me.  It has boosted my confidence and my  
self-esteem and motivated me to take more control  
of my life and play an important role in decisions about  
my healthcare.” 
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Working in partnership with key stakeholders,  
the Department of Health should:
1. Develop an AF strategy for Northern Ireland which will:
• drive forward service improvement in awareness, detection, 
support and management.   
• have a clear implementation with targets and timelines – 
including the appointment of an ‘AF Champion’.  
2. Establish a target to achieve at least 85% detected 
prevalence across Northern Ireland by March 2023 and 
have a proposed ambition of identifying 90% of expected 
prevalence by 2025. 
3. Create a holistic clinical pathway for AF in Northern Ireland 
involving patients and clinicians.
4. Invest in the use of proven technologies within clinical 
practice to detect AF, monitor implementation and  
allow audit.
5. Commission plans to increase AF detection rates by  
using targeted case finding based on AF risk factors. 
6. Take action to address the echocardiograms waiting list 
issue including outlining plans to tackle any workforce issues.  
7. Provide information and education to people living with 
AF to better support understanding, improve adherence to 
anticoagulation medication, and to manage their condition. 
8. Prioritise improving treatment and review of existing 
AF patients to prevent future strokes.  We recommend the 
following targets:
• Achieve less than 20% of patients with known AF admitted 
with stroke not correctly anticoagulated by March 2023
• Reduce individuals with a new diagnosis of AF after 
admission to a stroke unit from 23% to 20% by March 2023.
9. Commission the Public Health Agency to identify the most 
effective methods to raise public awareness of AF. We 
recommend the following targets:  
• increase public recognition of AF from 37% of the 
population to 50% of the population by 2025
• increase public awareness that AF can increase the  
risk of stroke by up to five times from the current base  
of 11% to 20% by 2025.
Recomendations
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In order to implement the recommendations, the Inquiry identified a range of 
actions to that could be taken forward – as part of a system wide strategic approach. 
Key issues Key actions
Support
Both healthcare  
professionals and people 
living with AF feel that 
understanding, management 
and adherence of AF could 
be improved with better 
information, education and 
support. A range of support 
mechanisms  
could be in-troduced to 
facilitate this.
• NICHS to support patients by to providing education,  
peer support and information to AF patients
• AF information evening held across each  
Trust on a quarterly basis
• NICHS to help develop an AF information pack/video for 
 use by Healthcare professionals when describing/educating 
new patients about AF
• Development of a Counselling template, with key information 
and signposting to additional information/support
• Develop a referral system to an AF clinic  
for those more complex cases or in need  
of enhanced time
Detection 
It is known that there is  
a proportion of undiagnosed 
AF patients in Northern Ireland. 
Every year a substantial 
number of people only 
discover they have an AF 
following a stroke. Increased 
detection provides an 
opportunity to medicate  
to help prevent stroke.
• Encourage targeted AF case finding programmes  
for those most at risk
• Use existing clinics/contact time with individuals with  
AF risk factors (hypertension, diabetes, Flu jab) to test  
for AF (use technology to help enable this). Opportunistic  
testing of those aged over 65.
• Follow up patients identified with AF; but below level for 
anticoagulant- flag them so rwhen each age 65, called back  
in for review
• Use risk factors to target populations
• Use resources outside GP to detect such as pharmacies
• NICHS Wellness checks 
Key issues Key actionsACTION  
PLAN  
Innovation /  
Best Practice
• Monitor success of AF clinic
• Possibility of an implementation group to discuss initiates 
throughout Northern Ireland 
• Work with relevant NHS/government organisations to  
address long waiting times especially for echos- increased 
number of cardiac physiologists.
• Engage with HIRANI and other key networks to identify an 
innovation pipeline to support future AF service delivery  
and transformation 
Practicalities
Software or technology  
in-vestment/ development 
to better detect and monitor 
people living with AF.
• The possibility of SSNAP to include a measure of  
DOAC adherence
• Software to identify potential non-adhering patients  
based on risk factors
• Software to identify people once they turn 65 who  
already presented with AF
• Update to Q-risk 3 to help prompt relevant questions
Adherence (Perfect)
These are individuals who 
have already been identified 
as having AF and are generally 
on medication. However,  
we know from the SSNAP data 
the medication may not be 
appropriate or may not be 
taken consistently.
• Adherence assessment; Review of DOAC patients to  
review adherence: existing patients reviewed. Direct 
questioning about adherence, followed by patient  
education and adherence strategies discussion.
• Practice pharmacists: review of current AF patients in  
the practice. Identification of patients who may be suitable for 
a change to DOAC or patients who have not been reviewed.
• Standardised information given to all patients  
regarding anticoagulation medicine
• Education of clinicians of appropriate anticoagulant 
medication
• Regular or annual reviews of all AF patients
Public awareness
Both patients and clinicians 
identified the lack of 
knowledge or understanding 
about what AF is, its risk 
factors or consequences. 
Patients felt that the 
acceptance and life with AF 
would be improved with better 
public awareness. Clinicians 
also felt this may improve 
detection and adherence.
• Public awareness campaign to highlight what AF is,  
risk factors, and consequences.
• Educating people to monitor their own pulse rhythm
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GLOSSARY 
A
Ablation – a treatment that aims to control 
or correct certain types of abnormal heart 
rhythms.
Anti-arrhythmic medications — medicines 
which aim to return the heart rhythm back to 
normal.
Anticoagulants — a group of medicines used to 
prevent harmful blood clots from forming.
Antithrombotic medication — drugs which 
reduce the formation of blood clots. There are 
two classes of antithrombotic drugs: anticoagu-
lants and antiplatelets (such as aspirin). Aspirin 
is no longer recommended in the prevention of 
strokes associated with AF.
Arrhythmia — an abnormal heart rhythm.
Atria — the upper chambers of the heart.
Atrial Fibrillation — an irregular heart rate that 
increases the risk of stroke.
C
Cardiac physiologist — health care profession-
al who carries out cardiac tests, such as echo-
cardiograms, ECGs, Holter monitors (24-hour 
ECG) etc.
Cardiology — medical speciality relating to the 
diagnosis and treatment of heart disease.
Cardiovascular disease — includes all the dis-
eases of the heart and circulation.
Cardioversion – involves using a defibrillator 
to give a controlled electric shock to return the 
heart rhythm to normal
Case-finding — a strategy used to identify pa-
tients with a certain condition.
Coagulation tests — measurement of how long 
a person’s blood takes to clot.
Cohort — a group of subjects with a common 
defining characteristic.
D
Demographic — characteristics of a given  
population.
Direct oral anticoagulant — a newer class of  
anticoagulation medications.
E
Electrocardiograph — a test that gives in-
formation about the electrical activity of your 
heart. The ECG helps to identify the source of 
the abnormal rhythm.
F
Fatigue — persistent feeling of tiredness.
G
GP — a primary care doctor.
H
Heart attack — damage to a part of the heart 
muscle caused by a sudden loss of blood flow to 
a part of the heart.
Heart failure — when the heart becomes less 
effective at pumping blood around the body.
Heart rate — how quickly the heart beats.
Heart rhythm — how regular or irregular the 
beats are.
High blood pressure — when the pressure of 
blood running through the arteries is too high 
(consistently over 140/90mmHg) it can have 
negative effects on the cardiovascular system.
Holter monitoring — a technique involving 
continuous recording on an electrocardiogram 
(ECG) over 24 hours, or longer. The patient 
wears the device on a belt with electrodes  
attached to their chest.
I
INR The international normalised ratio (INR)  
is a laboratory measurement of how long it  
takes blood to form a clot. It is used to  
determine the effects of oral anticoagulants  
on the clotting system
Ischaemic stroke — a stroke caused by a block-
age cutting off the blood supply to the brain.
L
Long term condition — conditions for which 
there is currently no cure and which are  
managed with drugs and other treatment.
M
Mortality — another word for death, when  
considered on a large scale.
O
Obesity — the term “obese” describes a person 
who’s very overweight, with a lot of body fat.
P
Palpitations — the sensation of feeling your 
heartbeat sometimes described as a thumping 
or fluttering in the chest.
Prevalence — a statistical concept referring to 
the number of cases of a disease that are  
present in a particular population at a given time.
Primary care — health care provided in the 
community. It is usually the first point of contact 
for patients and involves providing care for  
common illnesses and long term conditions.
R
Rate control — giving treatment to control  
the rate of the heartbeat, so that the heart  
beats more slowly, even if the heartbeat  
remains irregular.
Risk factor — something that increases your risk 
of developing a disease or condition.
Rhythm control — giving treatment to try to get 
the heart back to a normal rhythm.
S
Secondary care — medical care provided by a 
specialist, usually upon referral by primary care.
Sleep apnoea — a condition where the walls of 
the throat relax and narrow during sleep, inter-
rupting normal breathing.
Stroke — a stroke is a brain attack which hap-
pens when the blood supply to part of your brain 
is cut off.
T
Thrombectomy — a treatment that removes  
a blood clot with a mechanical device.
Thromboembolism — an obstruction to blood 
flow due to a blood clot in a deep vein, usually 
the legs (DVT) or the lungs (PE).
Thrombolysis — a process to that uses  
medication to dissolve a blood clot in the  
coronary arteries or in the arteries leading  
to the brain.
Transient Ischaemic Attack — is the same as  
a stroke, except that the symptoms only last for  
a short amount of time because the blockage that 
stops the blood getting to the brain is temporary.
V
Valvular heart disease — disease of the heart 
valves, which can affect the flow of blood,  
putting extra strain on the heart.
Vascular disease — disease of the blood vessels.
W
Warfarin — the most widely prescribed  
anticoagulant. It decreases the clotting ability  
of the blood, and so reduces the risk of blood 
clots forming
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APPENDIX
Dr John Winter is Chairperson and GP lead of the Ards  
ICP. He qualified from Queen’s University Belfast in 1978  
and practiced in Ards hospital for 3 years. Subsequently,  
he combined working in church and counselling organisations  
with part time sessional general practice. From 1996-2000,  
he undertook full time medical work in the City, Holywell and 
Ulster hospitals, gaining membership of the Royal College of 
General Practitioners and diplomas in Mental Health, Child  
Health and Geriatric Medicine.
Dr Winter recently retired having been in a GP Practice  
in Newtownards since 2000. He became a GP Trainer in  
2003, and subsequently, senior partner in the practice.
Dr Brian Gallen has been a Consultant Stroke Physician 
and Geriatrician in the South West Acute Hospital in 
Enniskillen since 2015.
He has a particular interest in clinical education, a subject  
in which he has a Postgraduate Certificate.
He has a wide range of clinical experience throughout 
Northern Ireland having worked for all 5 of Northern 
Ireland’s Health and Social Care Trusts. He has developed  
a keen interest in development of stroke services for 
different populations and equitability of access to stroke 
services such as TIA, stroke thrombolysis, rehabilitation  
and mechanical thrombectomy.
Dr Niamh Kennedy, is a Lecturer in Psychology at the 
Ulster University and has been commissioned by NICHS  
to oversee the AF Inquiry.
Niamh was previously a Lecturer in Rehabilitation 
Neuroscience at the University of East Anglia. Her  
research area concentrates on improving outcomes  
for stroke survivors.
In 2018 she carried out the research that lead to the 
‘Struggling to recover’ Report about life after stroke in 
Northern Ireland.
Neil Johnston is the Public Affairs and Policy Manager  
for Northern Ireland Chest Heart and Stroke. 
Neil has worked for Chest Heart and Stroke for 10 years 
he develops the charities policy positions, responses to 
government consultations and seeks opportunites to 
promote improved health and social care across chest, 
heart and stroke conditions.
Clare Murray is the Lead General Practice Pharmacist  
for East Belfast Federation of Family Practices. She has 
been a practice pharmacist for the past three years  
having previously been employed in Boots Pharmacy  
for over seven years. 
In addition to holding a Master’s in pharmacy Clare holds  
a Post Graduate Certificate in Independent Prescribing. 
Michael Jackson is Lead Pharmacist for Cardiothoracic 
Services at Belfast Health & Social Care Trust. He has  
over 25 years hospital experience in England and Northern 
Ireland. Michael leads a pharmacy team, delivering services to 
regional Cardiology, Cardiothoracic, Pulmonary Hypertension 
teams as well as providing anticoagulation services.
His role is split between managing the pharmacy team and 
leading adult and paediatric pharmacist clinics (pulmonary 
hypertension and anticoagulation).
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